News
Combining two multiple sclerosis treatments has no clinical benefit, study finds
BMJ 2013; 346 doi: https://doi.org/10.1136/bmj.f1719 (Published 14 March 2013) Cite this as: BMJ 2013;346:f1719
- Lilian Anekwe
- 1BMJ Evidence Centre
Combining glatiramer and interferon beta in patients with relapsing-remitting multiple sclerosis does not reduce symptoms or disability over three years, when compared with either treatment alone, a study has found.
The study, which was funded by the US National Institutes of Health, looked at the effects …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.